Toggle navigation image image
Toggle navigation logologo
image image
  • About Inflarx
    • Leadership Team
    • Board
  • R&D
    • Pipeline
    • Products & Technology
      • Technology
      • Vilobelimab
      • INF904
      • IFX002
    • Clinical Development
      • Pyoderma Gangraenosum
      • COVID-19
      • cSCC
      • Clinical Trials
    • Publications & Posters
  • Investors
    • Press Releases
    • Events & Presentations
    • Financial Information
    • Share Information
    • Analyst Coverage
    • Corporate Governance
    • Annual/Extraordinary General Meetings
    • E-mail alerts
  • Career
    • Open Positions

Financial-Information

  • Home
  • Investors
  • Financial Information

Financial-Information InflaRx SEC filings and financial reports

The following list represents all InflaRx SEC filings and financial reports. 

DateFiling TypeFiling DescriptionDownload / View
2023-09-11 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-08-30 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-08-10 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-07-12 424B5 Prospectus [Rule 424(b)(5)]
2023-07-11 EFFECT Notice of Effectiveness
2023-06-30 F-3 Registration statement by foreign private issuers
2023-06-28 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-06-21 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-05-11 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-27 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-24 SC 13G Statement of acquisition of beneficial ownership by individuals
2023-04-17 SC 13G Statement of acquisition of beneficial ownership by individuals
2023-04-13 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-13 424B5 Prospectus [Rule 424(b)(5)]
2023-04-11 424B5 Prospectus [Rule 424(b)(5)]
2023-04-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-04-04 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-03-22 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023-03-22 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
2023-02-13 SC 13G/A Statement of acquisition of beneficial ownership by individuals
2023-01-05 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]





 

Quick Links
  • Impressum
  • Privacy
  • Products & Technology
  • News
  • Career
  • Disclaimer
  • Contact
  • Newsletter
Contact Jena

InflaRx N.V. / InflaRx GmbH
Winzerlaer Str. 2
07745 Jena

+49 3641 508 180

info@inflarx.de

InflaRx on Linkedin

Contact Munich

InflaRx N.V. / InflaRx GmbH
Fraunhoferstraße 22
82152 Martinsried

+49 89 414 189 78 00

info@inflarx.de

Contact Ann Arbor

InflaRx Pharmaceuticals Inc.
600 S. Wagner Rd.
Ann Arbor, MI 48103

info@inflarx.de

© Copyright 2017 All Rights Reserved.
  • Developed by Ementals